| Application no. and date | 18772885.2 (espacenet) (Federated) (European Patent Register), 20180823 | | Patent/reg. no. and date | DK/EP 3672949, 20221221 | | Publication date | 20200701 | | Priority no. and date | US 201762549225 P, 20170823 | | EP pub. no. and date |
EP 3672949 20200701 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 168034/BT/GP | | Inventor | VISSER, Michael Scott, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
FAZAL, Aleem, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
BECKWITH, Rohan Eric John, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
TICHKULE, Ritesh Bhanudasji, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
BONAZZI, Simone, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
CERNIJENKO, Artiom, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/4545 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) , C07D 401/14 (2006.01) , C07D 407/14 (2006.01) , C07D 409/14 (2006.01) , C07D 413/14 (2006.01) , C07D 417/14 (2006.01) , C07D 471/04 (2006.01) , C07D 487/04 (2006.01) , C07D 487/08 (2006.01) , C07D 495/04 (2006.01) , C07D 513/04 (2006.01) | | Title | 3-(1-OXOISOINDOLIN-2-YL)PIPERIDIN-2,6-DIONDERIVATER OG ANVENDELSER DERAF | | Int. application no. | IB2018056400 | | Int. publication no. | WO2019038717 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
